C11orf95 Activators
C11orf95 can engage various intracellular signaling pathways to modulate its activity. Forskolin, known for its ability to directly stimulate adenylyl cyclase, increases the level of cAMP within the cell, a messenger that plays a pivotal role in the activation of protein kinase A (PKA). PKA, in turn, can phosphorylate a wide array of proteins, including C11orf95. Similarly, Isoproterenol, a synthetic catecholamine, binds to beta-adrenergic receptors, triggering a cascade that also leads to the elevation of cAMP and subsequent activation of C11orf95 through PKA. Prostaglandin E2 (PGE2) operates through its E-prostanoid receptors to stimulate adenylate cyclase, again bolstering cAMP levels and activating PKA, which may target C11orf95. Another agent, IBMX, indirectly promotes cAMP accumulation by inhibiting phosphodiesterases, the enzymes responsible for cAMP breakdown, thus facilitating C11orf95 activation via the PKA pathway.
Anisomycin, by inhibiting protein synthesis, can activate stress-activated protein kinases such as JNK which may lead to the modification of C11orf95. The activation of epidermal growth factor receptor (EGFR) by Epidermal Growth Factor leads to a series of phosphorylation events through the MAPK/ERK pathway, which may include C11orf95 if it is a part of this signaling network. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could phosphorylate C11orf95 if it is within PKC's substrate profile. Ionomycin, by increasing intracellular calcium levels, can activate calcium/calmodulin-dependent protein kinases (CaMKs), potentially leading to the activation of C11orf95. Insulin binds to its receptor and induces a signaling cascade through the PI3K/Akt pathway, which could encompass the modulation of C11orf95 activity. Lastly, Bradykinin and Histamine, through their respective receptors, activate phospholipase C or adenylyl cyclase pathways, leading to the activation of PKC or PKA, and possibly influencing C11orf95 activity, while Sildenafil, by preventing the breakdown of cGMP, can activate protein kinases that may play a role in the functional regulation of C11orf95.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that acts as an agonist for beta-adrenergic receptors, leading to activation of adenylyl cyclase and a subsequent rise in cAMP levels which could activate C11orf95 through the cAMP signaling pathway. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its E-prostanoid receptors, which can stimulate adenylate cyclase activity, leading to an increase in cAMP and activation of protein kinase A (PKA). PKA can then phosphorylate various substrates including C11orf95, resulting in its activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) is a non-specific inhibitor of phosphodiesterases, enzymes that break down cAMP. Inhibition of phosphodiesterases by IBMX leads to increased cAMP levels, which can activate protein kinase A (PKA), potentially resulting in the phosphorylation and activation of C11orf95. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs) such as JNK. The activation of JNK pathway can lead to the phosphorylation of various substrates, which could include C11orf95 if it is a substrate or part of the pathway regulated by SAPKs. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a wide range of substrates. Assuming C11orf95 is a PKC substrate or is involved in pathways regulated by PKC, PMA would lead to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, activating calmodulin and calcium/calmodulin-dependent protein kinases (CaMKs). If C11orf95 is regulated by CaMKs or is part of calcium signaling pathways, ionomycin-induced calcium influx could lead to the activation of C11orf95. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin binds to its receptor, leading to autophosphorylation and activation of the receptor's intrinsic tyrosine kinase activity. This initiates a cascade of downstream signaling involving PI3K/Akt pathway. If C11orf95 is a downstream target of the PI3K/Akt pathway or is modulated by it, insulin could activate C11orf95 through this signaling route. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin binds to B2 receptors, which can activate phospholipase C (PLC) and lead to the production of inositol triphosphate (IP3) and diacylglycerol (DAG), secondary messengers that increase intracellular calcium and activate protein kinase C (PKC). If C11orf95 is part of the PLC/PKC signaling pathway, bradykinin could result in activation of C11orf95. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to H1 or H2 receptors, with H2 receptors being coupled to Gs proteins, which activate adenylyl cyclase, increasing cAMP levels. Increased cAMP can activate PKA, which may phosphorylate and thus activate C11orf95, provided that C11orf95 is part of the signaling pathways involving cAMP. | ||||||